Next Generation News and Research

RSS

South Korean city shows SARS-CoV-2 clade shift from V to GH over time

A new paper from South Korea describes the evolving SARS-CoV-2 genome in a single city, that of Gwangju, in the southwestern region of this country.

21 Dec 2020

Research may lead to better treatment and vaccines for Ebola, COVID-19

In the midst of a global pandemic with COVID-19, it's hard to appreciate how lucky those outside of Africa have been to avoid the deadly Ebola virus disease.

21 Dec 2020

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of BI 767551, a new SARS-CoV-2 neutralizing antibody.

18 Dec 2020

Researchers use machine intelligence to improve brain-mapping technique

Scientists in Japan's brain science project have used machine intelligence to improve the accuracy and reliability of a powerful brain-mapping technique, a new study reports.

18 Dec 2020

PVP at Boston Children's awarded $1 million to extend research into adjuvant-based vaccines

For a vaccine to be most effective, sometimes nature needs a little 'extra' something. That something is often an adjuvant -- small molecules added to a vaccine that boost the body's immune response.

17 Dec 2020

Mogrify solidifies IP position surrounding core technology and expands platform algorithm to enhance cell conversion

Mogrify today announced it had secured the assignment of the foundational intellectual property underpinning its core direct cell conversion technology.

17 Dec 2020

Researchers identify neurons that regulate nausea-like responses in mice

At some point, everyone experiences nausea. Whether it occurs after unwisely eating a week-old slice of pizza or as an accompaniment to a serious infection, that queasy, unsettling sensation centered around the stomach is a signal that something is amiss within the body and typically portends a bout of vomiting.

17 Dec 2020

TRIUMF and Fusion Pharmaceuticals to develop next-generation radiopharmaceuticals

TRIUMF, Canada's particle accelerator center, today announced it has entered into a collaboration agreement with Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.

17 Dec 2020

New screening platform can be used to discover more effective drugs for type 1 diabetes

With nearly 2 million Americans battling type 1 diabetes, it is no surprise that clinical therapies for the disease are constantly evolving and improving.

16 Dec 2020

Report highlights research challenges and opportunities to advance cancer care

A new report finds that despite progress in the decline of cancer mortality, there are still critical gaps including the need to develop better tools and explore research opportunities that would lead to limiting cancer as a major health concern.

16 Dec 2020

SARS-CoV-2 unique deletion variants found in clinical specimens

While participating in the SPHERES Consortium project, US researchers sequenced 2,726 clinical patient specimens gathered in March 2020 and identified eight unique ORF7a deletion variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their results are currently available on the bioRxiv* preprint server.

15 Dec 2020

Research could lead to potential new treatments for mutant RAS-driven cancers

Scientists have dedicated huge amounts of time and resources to better understanding the causes and mechanisms of cancer growth.

15 Dec 2020

SIMON – The Machine Learning Platform Paving the Future of Vaccine Development

A machine learning algorithm developed by the Oxford Vaccine Group promises more effective vaccine development for several diseases, including COVID-19.

15 Dec 2020

New combination therapy has potential to treat aggressive cancers with common mutations

Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.

14 Dec 2020

Moffitt Cancer Center finds a way for researchers and patients to engage with each other

Behind every new cancer treatment and scientific breakthrough is a research team. However, because they spend most of their time in their labs, basic science researchers rarely get to meet the patients who benefit most from their work.

14 Dec 2020

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

As part of its Wave 1 Pipeline Market Opportunity Call, Takeda Pharmaceutical Company Limited provided an update on its pipeline portfolio, which has the potential to contribute significantly to revenue growth for the company over the next decade.

From Takeda 10 Dec 2020

Tomatoes could become a new, natural source of Parkinson's disease drug

Scientists have produced a tomato enriched in the Parkinson's disease drug L-DOPA in what could become a new, affordable source of one of the world's essential medicines.

9 Dec 2020

Study findings can guide personalized breast cancer therapies based on melatonin

A Brazilian study published in the Journal of Pineal Research describes a group of genes potentially regulated by the hormone melatonin in some types of cancer, especially breast cancer.

8 Dec 2020

Study highlights rising infant health inequality in the U.S.

After several decades of improvement, inequality in infant health is once again on the rise in the United States, a pair of Brown University researchers has found.

8 Dec 2020

Study highlights previously unknown mechanisms involved in myeloma resistance

A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, conducted the first prospective clinical trial investigating spatial heterogeneity in patients with either relapsed/refractory or newly diagnosed multiple myeloma.

7 Dec 2020

Next Generation News and Research

South Korean city shows SARS-CoV-2 clade shift from V to GH over time

Research may lead to better treatment and vaccines for Ebola, COVID-19

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Researchers use machine intelligence to improve brain-mapping technique

PVP at Boston Children's awarded $1 million to extend research into adjuvant-based vaccines

Mogrify solidifies IP position surrounding core technology and expands platform algorithm to enhance cell conversion

Researchers identify neurons that regulate nausea-like responses in mice

TRIUMF and Fusion Pharmaceuticals to develop next-generation radiopharmaceuticals

New screening platform can be used to discover more effective drugs for type 1 diabetes

Report highlights research challenges and opportunities to advance cancer care

SARS-CoV-2 unique deletion variants found in clinical specimens

Research could lead to potential new treatments for mutant RAS-driven cancers

SIMON – The Machine Learning Platform Paving the Future of Vaccine Development

New combination therapy has potential to treat aggressive cancers with common mutations

Moffitt Cancer Center finds a way for researchers and patients to engage with each other

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

Tomatoes could become a new, natural source of Parkinson's disease drug

Study findings can guide personalized breast cancer therapies based on melatonin

Study highlights rising infant health inequality in the U.S.

Study highlights previously unknown mechanisms involved in myeloma resistance

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News